JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Lifitegrast sodium (SAR 1118) is a novel and potent integrinlymphocyte function-associated antigen-1 (LFA-1) antagonist with the potential for Treatment of Dry Eye Disease. It inhibitsJurkat T cell attachment to ICAM-1 with an IC50 of 2.98 nM.
References: Lifitegrast, a Novel Integrin Antagonist for Treatmentof Dry Eye Disease. Ocul Surf. 2016 Apr; 14(2):207-15.2. Sun Y, et al. Corneal inflammation is inhibited by the LFA-1antagonist, lifitegrast (SAR 1118). J Ocul Pharmacol Ther. 2013May; 29(4):395-402
Related CAS #: 1119276-80-0 (sodium salt) 1025967-78-5 (free)
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Recommend by mail
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!